Diagnostic and Therapeutic Considerations in Concurrent Plasma Cell Dyscrasia and Amyloidosis

Muhamed Baljevic

doi:10.5339/qmj.2022.44

Diagnostic and Therapeutic Considerations in Concurrent Plasma Cell Dyscrasia and Amyloidosis

Muhamed Baljevic

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	44
Journal	Qatar Medical Journal
Volume	2022
Issue number	3
DOIs	https://doi.org/10.5339/qmj.2022.44
State	Published - 2022

Keywords

amyloidosis
diagnosis
plasma cell dyscrasia

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.5339/qmj.2022.44

Cite this

@article{d8c182cc33314fd18c7d2a3876718b86,

title = "Diagnostic and Therapeutic Considerations in Concurrent Plasma Cell Dyscrasia and Amyloidosis",

keywords = "amyloidosis, diagnosis, plasma cell dyscrasia",

author = "Muhamed Baljevic",

year = "2022",

doi = "10.5339/qmj.2022.44",

language = "English (US)",

volume = "2022",

journal = "Qatar Medical Journal",

issn = "0253-8253",

publisher = "Hamad Medical Corporation, State of Qatar",

number = "3",

}

TY - JOUR

T1 - Diagnostic and Therapeutic Considerations in Concurrent Plasma Cell Dyscrasia and Amyloidosis

AU - Baljevic, Muhamed

PY - 2022

Y1 - 2022

KW - amyloidosis

KW - diagnosis

KW - plasma cell dyscrasia

UR - http://www.scopus.com/inward/record.url?scp=85140250185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140250185&partnerID=8YFLogxK

U2 - 10.5339/qmj.2022.44

DO - 10.5339/qmj.2022.44

M3 - Letter

C2 - 36258756

AN - SCOPUS:85140250185

SN - 0253-8253

VL - 2022

JO - Qatar Medical Journal

JF - Qatar Medical Journal

IS - 3

M1 - 44

ER -

Diagnostic and Therapeutic Considerations in Concurrent Plasma Cell Dyscrasia and Amyloidosis

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this